VENBIO GLOBAL STRATEGIC GP III, LTD
SEC CIK 1869300 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARTV | Artiva Biotherapeutics, Inc. | 10% | 1.06M | $5.00M | — | 3 | 2024-07-22 | 2024-07-22 |
Most active insiders at ARTV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $92.68M | — |
| 2 | GC Corp. | 10% | $16.50M | — |
| 3 | Aslan Fred | Pres, CEO, Dir | — | $1.38M |
| 4 | Banerjee Subhashis | Chief Medical Off | — | $179.5K |
| 5 | Horan Christopher | Chief Tech Ops Off | — | $178.7K |
| 6 | Bush Jennifer | COO, CLO, Secy, Compliance Off | — | $172.8K |
| 7 | Raymon Heather | SVP, Research, Development | — | $27.9K |
| 8 | Krishnamohan Neha | CFO | — | — |
| 9 | Miralles Gines Diego | Pres, Head of R, D | — | — |
| 10 | Huston Thad Allen | CFO | — | — |
VENBIO GLOBAL STRATEGIC GP III, LTD made no open-market trades at ARTV in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-22 | 2024-07-22 | ARTV | Artiva Biotherapeutics, Inc. | VENBIO GLOBAL STRATEGIC GP III, LTD | 10% | C - Cnv Deriv | — | +1.06M | 1.06M | New | — |
| D | 2024-07-22 | 2024-07-22 | ARTV | Artiva Biotherapeutics, Inc. | VENBIO GLOBAL STRATEGIC GP III, LTD | 10% | J - Other | — | +461.7K | 1.52M | +44% | — |
| D | 2024-07-22 | 2024-07-22 | ARTV | Artiva Biotherapeutics, Inc. | VENBIO GLOBAL STRATEGIC GP III, LTD | 10% | P - Purchase | $12.00 | +416.7K | 1.94M | +27% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations